Samlyn Capital, LLC Jazz Pharmaceuticals PLC Transaction History

Samlyn Capital, LLC

$6.21 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$115.19 - $132.77 $48.9 Million - $56.3 Million	-424,251 Reduced 68.19%	197,925 $23.8 Million
Q4 2023 Feb 14, 2024	SELL	$114.26 - $136.0 $84.2 Million - $100 Million	-736,645 Reduced 54.21%	622,176 $76.5 Million
Q3 2023 Nov 14, 2023	BUY	$122.0 - $145.31 $1.54 Million - $1.83 Million	12,591 Added 0.94%	1,358,821 $176 Million
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $68.3 Million - $82.1 Million	557,605 Added 70.71%	1,346,230 $167 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $22.3 Million - $26.8 Million	166,789 Added 26.82%	788,625 $115 Million
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $54.7 Million - $67.4 Million	-421,479 Reduced 40.4%	621,836 $99.1 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $20.3 Million - $25.8 Million	-160,244 Reduced 13.31%	1,043,315 $139 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $37.4 Million - $44.6 Million	264,146 Added 28.12%	1,203,559 $188 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $36.8 Million - $45.6 Million	283,744 Added 43.28%	939,413 $146 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $15.9 Million - $19.3 Million	132,383 Added 25.3%	655,669 $83.5 Million
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $24.6 Million - $35.3 Million	191,253 Added 57.6%	523,286 $68.1 Million
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $21.1 Million - $24.5 Million	131,614 Added 65.67%	332,033 $59 Million
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $30.1 Million - $34.8 Million	200,419 New	200,419 $32.9 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.7B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samlyn Capital, LLC with notifications on news.

Account